PMID- 27603724 OWN - NLM STAT- MEDLINE DCOM- 20170526 LR - 20190221 IS - 1552-5783 (Electronic) IS - 0146-0404 (Linking) VI - 57 IP - 11 DP - 2016 Sep 1 TI - Optic Nerve Head Morphology in Nonarteritic Anterior Ischemic Optic Neuropathy Compared to Open-Angle Glaucoma. PG - 4632-40 LID - 10.1167/iovs.16-19442 [doi] AB - PURPOSE: To compare optic nerve head (ONH) morphology of optic nerve atrophy between eyes with primary open-angle glaucoma (POAG) and eyes with a history of nonarteritic anterior ischemic optic atrophy (NAION) using enhanced depth imaging (EDI) with spectral-domain optical coherence tomography (SD-OCT). METHODS: In this cross-sectional study, 121 eyes of 91 patients consisted of moderate to severe POAG (n = 32 eyes), visual field mean deviation-matched NAION (n = 30 eyes) and their fellow eyes (n = 30 eyes), and healthy controls (n = 29). The optic discs were scanned using SD-OCT and measurements were obtained using HEYEX software 6.0. Lamina cribrosa (LC) thickness and anterior lamina cribrosa depth (ALD) at three scans (midsuperior, central, and midinferior) were determined and compared. In addition, prelaminar tissue thickness was measured at three points of a single central scan. RESULTS: There was no significant difference in the visual field mean deviation (MD) between the NAION and POAG groups (P > 0.99), but both groups had a significantly worse MD than the healthy group (P < 0.001). The NAION and POAG groups had similar peripapillary retinal nerve fiber layer (pRNFL) thickness (P < 0.99). Eyes with POAG had greater ALD and thinner LC than control eyes and NAION eyes in all regions of the ONH (P < 0.001 for both). There was a marked prelaminar tissue thinning in POAG eyes compared to control and NAION eyes (P < 0.001). Lamina cribrosa thickness and ALD of NAION eyes were not different from their fellow eyes and control eyes. Although prelaminar thickness was thinner in NAION eyes compared to their fellow eyes (P = 0.005), it was thicker than in control eyes (P < 0.001). CONCLUSIONS: Despite profound thinning and posterior displacement of LC in POAG, the thickness and position of LC in NAION eyes are similar to those seen in healthy control and their fellow eyes. FAU - Fard, Masoud Aghsaei AU - Fard MA AD - Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. FAU - Afzali, Marjan AU - Afzali M AD - Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. FAU - Abdi, Parisa AU - Abdi P AD - Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. FAU - Chen, Rebecca AU - Chen R AD - Case Western Reserve University School of Medicine, Cleveland, Ohio, United States 3Department of Ophthalmology, University of California-San Francisco, San Francisco, California, United States. FAU - Yaseri, Mehdi AU - Yaseri M AD - Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran 4Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran. FAU - Azaripour, Ebrahim AU - Azaripour E AD - Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. FAU - Moghimi, Sasan AU - Moghimi S AD - Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran 3Department of Ophthalmology, University of California-San Francisco, San Francisco, California, United States. LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Cross-Sectional Studies MH - Disease Progression MH - Female MH - Follow-Up Studies MH - Glaucoma, Open-Angle/*diagnosis/physiopathology MH - Humans MH - Image Enhancement MH - *Intraocular Pressure MH - Male MH - Middle Aged MH - Optic Disk/*pathology MH - Optic Neuropathy, Ischemic/*diagnosis/physiopathology MH - Retinal Ganglion Cells/pathology MH - Retrospective Studies MH - Severity of Illness Index MH - Tomography, Optical Coherence/*methods MH - *Visual Fields EDAT- 2016/09/08 06:00 MHDA- 2017/05/27 06:00 CRDT- 2016/09/08 06:00 PHST- 2016/09/08 06:00 [entrez] PHST- 2016/09/08 06:00 [pubmed] PHST- 2017/05/27 06:00 [medline] AID - 2552273 [pii] AID - 10.1167/iovs.16-19442 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4632-40. doi: 10.1167/iovs.16-19442.